Advertisement

Evaluation and Management of Heavy Vaginal Bleeding (Noncancerous)

  • Bridget Kelly
    Affiliations
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    University of Wisconsin Obstetrics and Gynecology Clinic, 2402 Winnebago Street, Madison, WI 53704, USA
    Search for articles by this author
  • Emily Buttigieg
    Correspondence
    Corresponding author. University of Wisconsin Obstetrics and Gynecology Clinic, 20 South Park, Madison, WI 53715.
    Affiliations
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    University of Wisconsin Obstetrics and Gynecology Clinic, 20 South Park, Madison, WI 53715, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. ACOG Practice Bulletin No. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women.
        Obstet Gynecol. 2012; 120: 197-206
      2. ACOG Committee Opinion No. 785: screening and management of bleeding disorders in adolescents with heavy menstrual bleeding.
        Obstet Gynecol. 2019; 134: e71-e83
        • Magnay J.L.
        • O’Brien S.
        • Gerlinger C.
        • et al.
        Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review.
        BMC Womens health. 2020; 20: 24
        • Wyatt K.M.
        • Dimmock P.W.
        • Walker T.J.
        • et al.
        Determination of total menstrual blood loss.
        Fertil Steril. 2001; 76: 125-131
        • Toxqui L.
        • Pérez-Granados A.M.
        • Blanco-Rojo R.
        • et al.
        A simple and feasible questionnaire to estimate menstrual blood loss: relationship with hematological and gynecological parameters in young women.
        BMC Womens Health. 2014; 14: 71
        • Janssen C.A.
        • Scholten P.C.
        • Heintz A.P.
        A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
        Obstet Gynecol. 1995; 85: 977-982
        • Reid P.C.
        • Coker A.
        • Coltart R.
        Assessment of menstrual blood loss using a pictorial chart: a validation study.
        BJOG. 2000; 107: 320-322
        • Munro M.G.
        • Critchley H.O.D.
        • Broder M.S.
        • et al.
        FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.
        Int J Gynecol Obstet. 2011; 113: 3-13
      3. ACOG Practice Bulletin No. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction.
        Obstet Gynecol. 2013; 122: 176-185
      4. ACOG Committee Opinion No. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive aged women.
        Obstet Gynecol. 2013; 121: 891-896
        • Brady P.C.
        • Carusi D.
        Vaginal hemorrhage.
        in: Handbook of consult and inpatient gynecology. Springer International Publishing, 2016: 31-51
        • Falotico J.M.
        • Shinozaki K.
        • Saeki K.
        • et al.
        Advances in the approaches using peripheral perfusion for monitoring hemodynamic status.
        Front Med. 2020; 7
        • Evans L.
        • Rhodes A.
        • Alhazzani W.
        • et al.
        Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021.
        Crit Care Med. 2021; 49: e1063-e1143
      5. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005 Nov;84(5):1345-51. doi: 10.1016/j.fertnstert.2005.05.035. PMID: 16275228.

        • Borzutzky C.
        • Jaffray J.
        Diagnosis and management of heavy menstrual bleeding and bleeding disorders in adolescents.
        JAMA Pediatr. 2020; 174: 186
        • Cowan B.D.
        • Morrison J.C.
        Management of abnormal genital bleeding in girls and women.
        New Engl J Med. 1991; 324: 1710-1715
        • Bennett G.L.
        • Andreotti R.F.
        • Lee S.I.
        • et al.
        ACR Appropriateness Criteria on abnormal vaginal bleeding.
        J Am Coll Radiol. 2011; 8: 460-468
        • Williams P.L.
        • Laifer-Narin S.L.
        • Ragavendra N.
        US of abnormal uterine bleeding.
        Radiographics. 2003; 23: 703-718
        • Bingol B.
        • Gunenc Z.
        • Gedikbasi A.
        • et al.
        Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography and hysteroscopy.
        J Obstet Gynaecol. 2011; 31: 54-58
        • Mahewux-Lacroix S.
        • Li F.
        • Laberge P.
        • et al.
        Imaging for polyps and leiomyomas in women with abnormal uterine bleeding: a systematic review.
        Obstet Gynecol. 2016; 128: 1425-1436
        • Van Den Bosch T.
        • Verguts J.
        • Daemen A.
        • et al.
        Pain experienced during transvaginal ultrasound, saline contrast sonohysterography, hysteroscopy and office sampling: a comparative study.
        Ultrasound Obstet Gynecol. 2008; 31: 346-351
        • Hubert J.
        • Bergin D.
        Imaging the female pelvis: when should MRI be considered?.
        J Pract Med Imag Management. 2011; 37: 9-22
        • DeVore G.R.
        • Owens O.
        • Kase N.
        Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding: a double-blind randomized control study.
        Obstet Gynecol. 1982; 59: 285-291
        • James A.H.
        • Kouides P.A.
        • Abdul-Kadir R.
        • et al.
        Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.
        Eur J Obstet Gynecol Reprod Biol. 2011; 158: 124-134
        • Emans S.J.
        • Laufer M.
        • DiVasta A.
        Abnormal vaginal bleeding in the adolescent.
        in: Emans Laufer Goldstein’s pediatric and adolescent Gynecology. 6th edition. Lippincot Williams and Wilkins, 2011: 159-167
        • Munro M.G.
        • Mainor N.
        • Basu R.
        • et al.
        Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding.
        Obstet Gynecol. 2006; 108: 924-929
        • Speroff L.
        • Darney P.
        Oral contraception.
        in: Clinical guide for contraception. 5th edition. Lippincott Williams & Wilkins, 2010: 19-152
        • Curtis K.M.
        • Tepper N.K.
        • Jatlaoui T.C.
        • et al.
        U.S. medical eligibility criteria for contraceptive use, 2016.
        MMWR Recomm Rep. 2016; 65: 1-103
        • Thorne J.
        • James P.
        • Reid R.
        Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?.
        Contraception. 2018; 98: 1-3
      6. AbbVie Inc. Oriahnn (elagolix, estradiol, and norethindrone capsules) [package insert]. U.S Food and Drug Administration website.
        (Available at:) (Accessed January 11, 2022)
      7. Pantheon Inc. Myfembree (relugolix, estradiol, and norethindrone acetate). U.S. Federal Drug Administration website.
        (Available at:) (Accessed January 11, 2022)
        • Bofill Rodriguez M.
        • Lethaby A.
        • Farquhar C.
        Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.
        Cochrane database Syst Rev. 2019; 9: CD000400
      8. ACOG Practice Bulletin No. 228: management of symptomatic uterine leiomyomas.
        Obstet Gynecol. 2021; 137: e100-e115
        • Schlaff W.D.
        • Ackerman R.T.
        • Al-Hendy A.
        • et al.
        Elagolix for heavy menstrual bleeding in women with uterine fibroids.
        New Engl J Med. 2020; 382: 328-340
        • Al-Hendy A.
        • Lukes A.S.
        • Poindexter A.N.
        • et al.
        Treatment of uterine fibroid symptoms with relugolix combination therapy.
        N Engl J Med. 2021; 384: 630-642
      9. ACOG Practice Bulletin No. 81: endometrial ablation.
        Obstet Gynecol. 2007; 109: 1233-1248
        • El-Nashar S.A.
        • Hopkins M.R.
        • Creedon D.J.
        • et al.
        Prediction of treatment outcomes after global endometrial ablation.
        Obstet Gynecol. 2009; 113: 97-106
      10. ACOG Committee Opinion No. 701: choosing the route of hysterectomy for benign disease.
        Obstet Gynecol. 2017; 129: 155-159
        • Napolitano L.M.
        • Kurek S.
        • Luchette F.A.
        • et al.
        Clinical practice guideline: red blood cell transfusion in adult trauma and critical care.
        Crit Care Med. 2009; 37: 3124-3157
        • Short M.W.
        • Domagalski J.E.
        Iron deficiency anemia: evaluation and management.
        Am Fam Physician. 2013; 87: 98-104
      11. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention.
        MMWR Recomm Rep. 1998; 47: 1-29
        • Powers J.M.
        • Buchanan G.R.
        Diagnosis and management of iron deficiency anemia.
        Hematol Oncol Clin North Am. 2014; 28: 729-745
        • Stoffel N.U.
        • Cercamondi C.I.
        • Brittenham G.
        • et al.
        Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.
        Lancet Haematol. 2017; 4: 524-533